Anthracycline-based regimens and trastuzumab related cardiotoxicity after adjuvant therapy in early breast cancer: A single center experience

被引：0
|
作者：
Iannace, A. [1 ]
Franzese, E. [2 ]
Losanno, T. [1 ]
Manna, G. [1 ]
Longo, F. [1 ]
Filomeno, L. [2 ]
Rossini, D. [1 ]
Seminara, P. [2 ]
机构：
[1] Univ Roma La Sapienza, Policlin Umberto I, Expt Med Oncol Unit A, Rome, Italy
[2] Univ Roma La Sapienza, Policlin Umberto I, Clin Med Oncol Unit A, Rome, Italy
来源：
EUROPEAN JOURNAL OF CANCER | 2013年 / 49卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
2086
引用
收藏
页码：S472 / S472
页数：1
相关论文
共 50 条
  • [1] Late cardiotoxicity in patients with breast cancer after taxane/anthracycline-based neoadjuvant and adjuvant chemotherapy
    Koroleva, I.
    Kopp, M. V.
    Kasulin, A. N.
    Kucheryavyy, J. A.
    Byakhov, M. J.
    JOURNAL OF CLINICAL ONCOLOGY, 2011, 29 (15)
  • [2] Trastuzumab-Related Cardiotoxicity Following Anthracycline-Based Adjuvant Chemotherapy: How Worried Should We Be?
    Morris, Patrick G.
    Hudis, Clifford A.
    JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (21) : 3407 - 3410
  • [3] Anthracycline-based adjuvant chemotherapy in breast cancer
    Gray, Richard
    LANCET, 2010, 375 (9729): : 1870 - 1871
  • [4] Prediction of trastuzumab-induced cardiotoxicity in breast cancer patients receiving anthracycline-based chemotherapy
    Wafaa S. El-Sherbeny
    Nesreen M. Sabry
    Radwa M. Sharbay
    Journal of Echocardiography, 2019, 17 : 76 - 83
  • [5] Prediction of trastuzumab-induced cardiotoxicity in breast cancer patients receiving anthracycline-based chemotherapy
    El-Sherbeny, Wafaa S.
    Sabry, Nesreen M.
    Sharbay, Radwa M.
    JOURNAL OF ECHOCARDIOGRAPHY, 2019, 17 (02) : 76 - 83
  • [6] Cardiotoxicity with adjuvant trastuzumab use in breast cancer: A single institution's experience
    Aldiab, Abdurrahman
    JOURNAL OF THE SAUDI HEART ASSOCIATION, 2010, 22 (03) : 133 - 136
  • [7] Cardiac Tolerability of Concurrent Administration of Trastuzumab and Anthracycline-Based Regimen as Adjuvant Chemotherapy for Breast Cancer
    Watanabe, Naoki
    Otsuka, Shoko
    Sasaki, Yoko
    Shimojima, Reiko
    Wani, Yoji
    Uchino, Kaori
    BREAST CARE, 2014, 9 (01) : 46 - 51
  • [8] Baseline diastolic dysfunction as a predictive factor of trastuzumab-mediated cardiotoxicity after adjuvant anthracycline therapy in breast cancer
    Alexandre Cochet
    Gaetan Quilichini
    Inna Dygai-Cochet
    Claude Touzery
    Michel Toubeau
    Alina Berriolo-Riedinger
    Bruno Coudert
    Yves Cottin
    Pierre Fumoleau
    François Brunotte
    Breast Cancer Research and Treatment, 2011, 130 : 845 - 854
  • [9] Baseline diastolic dysfunction as a predictive factor of trastuzumab-mediated cardiotoxicity after adjuvant anthracycline therapy in breast cancer
    Cochet, Alexandre
    Quilichini, Gaetan
    Dygai-Cochet, Inna
    Touzery, Claude
    Toubeau, Michel
    Berriolo-Riedinger, Alina
    Coudert, Bruno
    Cottin, Yves
    Fumoleau, Pierre
    Brunotte, Francois
    BREAST CANCER RESEARCH AND TREATMENT, 2011, 130 (03) : 845 - 854
  • [10] Effective Antiemetic Therapy Is Important With Adjuvant Anthracycline-based Chemotherapy in Breast Cancer
    Takala, Laura
    Barlund, Maarit
    Kellokumpu-Lehtinen, Pirkko-Liisa
    Pirkko, Liisa
    ANTICANCER RESEARCH, 2019, 39 (01) : 279 - 283
12345